Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
Percocet	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Left	O
lower-extremity	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mrs.	O
___	O
is	O
a	O
___	O
woman	O
with	O
metastatic	O
colorectal	O
cancer	O
s/p	O
LAR	O
(___)	O
c/b	O
lung	O
mets	O
s/p	O
resection	O
with	O
recurrence	O
and	O
sacral	O
mets	O
who	O
presents	O
with	O
LLE	O
weakness	O
x	O
2	O
weeks.	O
The	O
weakness	O
began	O
subtly,	O
but	O
has	O
steadily	O
progressed	O
to	O
the	O
point	O
where	O
she	O
required	O
a	O
cane	O
to	O
walk	O
a	O
few	O
days	O
prior	O
to	O
admission.	O
Also	O
with	O
increasing	O
L	O
back	O
pain	O
x	O
3	O
weeks.	O
No	O
trauma.	O
No	O
incontinence.	B-Urinary_incontinence
Has	O
baseline	O
neuropathy	O
in	O
feet,	O
but	O
no	O
worsening	O
numbness.	O
No	O
difficulty	O
with	O
speech.	O
No	O
fevers/chills/night	O
sweats.	O
Denies	O
cough,	O
shortness	O
of	O
breath,	O
chest	O
pain.	O
No	O
N/V/D.	O
Chronic	O
constipation.	B-Constipation
She	O
is	O
actively	O
undergoing	O
treatment	O
for	O
her	O
sacral	O
mets.	O
Current	O
treatment	O
includes:	O
___	O
C1W2	O
of	O
erbitux,	O
XRT	O
to	O
sacrum	O
(total	O
30Gy	O
completed	O
___	O
While	O
in	O
the	O
ED,	O
she	O
was	O
seen	O
by	O
Neurology,	O
who	O
felt	O
her	O
exam	O
was	O
"	O
notable	O
for	O
UMN	O
pattern	O
weakness	O
in	O
all	O
extremities,	O
with	O
the	O
greatest	O
weakness	O
in	O
her	O
___	O
-	O
still	O
in	O
an	O
UMN	O
pattern,	O
but	O
with	O
some	O
radicular	O
component	O
as	O
well.	O
Bilateral	O
extensor	O
plantar	O
responses	O
also	O
support	O
UMN	O
lesion.	O
Therefore,	O
she	O
has	O
evidence	O
of	O
a	O
cervical	O
myelopathy	O
by	O
exam;	O
a	O
concomitant	O
thoracic	O
myelopathy	O
can't	O
be	O
ruled	O
out.	O
She	O
does	O
also	O
have	O
evidence	O
of	O
a	O
left	O
L5	O
radiculopathy.	O
Etiology	O
of	O
concern	O
is	O
of	O
course	O
spinal	O
mets;	O
in	O
the	O
absence	O
of	O
these,	O
spondylosis	O
may	O
cause	O
a	O
cervical	O
myelopathy,	O
but	O
she	O
already	O
has	O
known	O
mets	O
to	O
the	O
sacrum....The	O
mild	O
abnormalities	O
on	O
mental	O
status	O
testing	O
can	O
be	O
seen	O
after	O
chemotherapy,	O
although	O
she	O
should	O
have	O
brain	O
imaging	O
at	O
some	O
point,	O
as	O
well."	O
An	O
emergent	O
Spine	O
MRI	O
with	O
and	O
without	O
contrast	O
was	O
recommended.	O
Several	O
hours	O
passed	O
before	O
MRI	O
was	O
available.	O
The	O
patient	O
was	O
then	O
premedicated	O
for	O
pain	O
and	O
anxiety	O
and	O
taken	O
down	O
for	O
MRI;	O
however,	O
soon	O
after	O
getting	O
on	O
the	O
table	O
she	O
refused	O
to	O
complete	O
the	O
exam.	O
The	O
study	O
was	O
aborted	O
and	O
she	O
was	O
brought	O
back	O
to	O
the	O
ED.	O
The	O
resident	O
caring	O
for	O
her	O
in	O
the	O
ED	O
was	O
unable	O
to	O
persuade	O
her	O
to	O
go	O
back	O
down	O
to	O
complete	O
the	O
study.	O
The	O
Heme	O
Onc	O
fellow	O
and	O
neurology	O
consult	O
resident	O
were	O
made	O
aware.	O
The	O
neurology	O
team	O
felt	O
there	O
was	O
no	O
indication	O
for	O
urgent	O
steroids	O
and	O
recommended	O
repeat	O
attempt	O
at	O
MRI	O
in	O
AM.	O
Also	O
while	O
in	O
the	O
ED	O
she	O
was	O
noted	O
to	O
have	O
a	O
6	O
point	O
Hct	O
drop	O
over	O
5	O
hours	O
(from	O
34.6	O
to	O
28.7).	O
he	O
was	O
guiac	O
positive	O
on	O
exam.	O
A	O
stat	O
CT	O
abd	O
was	O
done	O
to	O
rule	O
out	O
RP	O
bleed,	O
this	O
was	O
negative.	O
Hct	O
was	O
repeated	O
and	O
returned	O
at	O
30.3.	O
She	O
is	O
admitted	O
to	O
___	O
for	O
further	O
workup	O
and	O
management.	O
Past	O
Medical	O
History:	O
Oncologic	O
history:	O
The	O
patient	O
was	O
initially	O
diagnosed	O
with	O
colon	O
cancer	O
in	O
___	O
after	O
presenting	O
with	O
abdominal	O
pain	O
and	O
cramping.	O
She	O
underwent	O
low	O
anterior	O
resection	O
on	O
___	O
with	O
removal	O
of	O
a	O
2	O
x	O
4.3	O
x	O
0.7	O
cm	O
moderately	O
differentiated	O
adenocarcinoma	O
that	O
extended	O
to	O
the	O
serosal	O
surface.	O
___	O
lymph	O
nodes	O
were	O
involved	O
and	O
there	O
was	O
perineural	O
invasion.	O
On	O
___,	O
an	O
area	O
in	O
segment	O
4	O
of	O
the	O
liver	O
suspicious	O
for	O
metastasis	O
was	O
resected	O
and	O
her	O
gallbladder	O
was	O
removed.	O
Pathology	O
showed	O
the	O
lesion	O
was	O
benign.	O
She	O
had	O
stage	O
III,	O
T4,	O
N1,	O
M0	O
disease.	O
She	O
received	O
___	O
and	O
leucovorin	O
chemotherapy	O
from	O
___	O
to	O
___.	O
In	O
___,	O
she	O
developed	O
pulmonary	O
nodules.	O
On	O
___,	O
she	O
underwent	O
wedge	O
resection	O
of	O
the	O
right	O
lower	O
lobe,	O
right	O
upper	O
lobe,	O
and	O
right	O
middle	O
lobe	O
lesions.	O
The	O
right	O
lower	O
lobe	O
lesion	O
was	O
a	O
1	O
cm	O
adenocarcinoma,	O
the	O
right	O
upper	O
lesion	O
was	O
a	O
1.8	O
cm	O
adenocarcinoma,	O
and	O
the	O
right	O
middle	O
lobe	O
lesion	O
was	O
a	O
pleural	O
scar.	O
She	O
received	O
___,	O
oxaliplatin,	O
and	O
Avastin	O
from	O
___	O
to	O
___.	O
In	O
___,	O
she	O
developed	O
recurrent	O
lung	O
lesions	O
and	O
received	O
FOLFOX	O
and	O
Avastin	O
from	O
___	O
through	O
___.	O
Her	O
lung	O
lesions	O
stabilized	O
and	O
CyberKnife	O
radiotherapy	O
was	O
considered.	O
The	O
patient	O
and	O
her	O
physicians	O
instead	O
decided	O
to	O
treat	O
the	O
area	O
surgically.	O
She	O
underwent	O
a	O
right	O
upper	O
lobe	O
wedge	O
resection	O
on	O
___,	O
with	O
resection	O
of	O
an	O
FDG	O
avid	O
lesion.	O
In	O
___,	O
she	O
had	O
progression	O
of	O
bilateral	O
lung	O
and	O
pleural	O
disease.	O
She	O
received	O
FOLFOX	O
and	O
Avastin	O
from	O
___	O
to	O
___.	O
The	O
chemotherapy	O
was	O
stopped	O
to	O
give	O
the	O
patient	O
a	O
break	O
from	O
the	O
side	O
effects	O
of	O
therapy.	O
Most	O
recent	O
surveillance	O
CT	O
of	O
the	O
chest,	O
abdomen,	O
and	O
pelvis	O
on	O
___,	O
showed	O
an	O
increase	O
in	O
bilateral	O
pulmonary	O
nodules	O
compared	O
to	O
scan	O
performed	O
on	O
___.	O
PMH:	O
1.	O
Metastatic	O
colorectal	O
cancer	O
as	O
described	O
in	O
the	O
narrative.	O
2.	O
Hepatitis.	O
3.	O
Appendectomy	O
at	O
age	O
___.	O
4.	O
B12	O
deficiency.	O
5.	O
Hypothyroid	O
Social	O
History:	O
___	O
Family	O
History:	O
Noncontributory	O
Physical	O
Exam:	O
Vitals	O
-	O
T:	O
98.3	O
BP:102/62	O
HR:88	O
RR:15	O
02	O
sat:	O
100%	O
RA	O
GENERAL:	O
thin,	O
cachetic,	O
chronically	O
ill	O
appearing,	O
fatigued,	O
but	O
NAD	O
SKIN:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions	O
HEENT:	O
AT/NC,	O
EOMI,	O
PERRLA,	O
MMM	O
dry,	O
nontender	O
supple	O
neck,	O
no	O
LAD,	O
no	O
JVD	O
CARDIAC:	O
RRR,	O
S1/S2,	O
no	O
mrg	O
LUNG:	O
soft	O
crackles	O
b/l	O
bases	O
which	O
partially	O
clear	O
with	O
cough	O
ABDOMEN:	O
scaphoid,	O
nondistended,	O
+BS,	O
nontender	O
in	O
all	O
quadrants,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly.	O
RECTAL:	O
Guaic	O
positive.	O
PULSES:	O
1+	O
DP	O
pulses	O
bilaterally	O
NEURO:	O
CN	O
II-XII	O
intact.	O
No	O
pronator	O
drift.	O
Normal	O
rapid	O
alt	O
movements,	O
normal	O
finger	O
to	O
nose,	O
normal	O
heel	O
to	O
shin.	O
No	O
romberg.	O
sensory:	O
diminished	O
over	O
feet	O
to	O
light	O
touch,	O
symmetric.	O
DTR's	O
patellar	O
-	O
present	O
and	O
symmetric	O
b/l,	O
~1+;	O
toes	O
upgoing	O
b/l.	O
Strength:	O
___	O
b/l	O
upper	O
ext.	O
LLE:	O
___	O
at	O
hip	O
and	O
___	O
at	O
knee,	O
RLE	O
___	O
Pertinent	O
Results:	O
___	O
02:30PM	O
GLUCOSE-108*	O
UREA	O
N-12	O
CREAT-0.4	O
SODIUM-134	O
POTASSIUM-3.8	O
CHLORIDE-95*	O
TOTAL	O
CO2-28	O
ANION	O
GAP-15	O
___	O
02:30PM	O
CALCIUM-9.1	O
PHOSPHATE-3.3	O
MAGNESIUM-1.9	O
___	O
02:30PM	O
WBC-7.5	O
RBC-3.32*	O
HGB-9.7*	O
HCT-28.7*	O
MCV-87	O
MCH-29.3	O
MCHC-33.9	O
RDW-13.8	O
___	O
02:30PM	O
NEUTS-82.9*	O
LYMPHS-11.4*	O
MONOS-3.9	O
EOS-1.6	O
BASOS-0.3	O
IMAGING:	O
======	O
CT	O
Abd/Pelvis	O
(___):	O
IMPRESSION:	O
1.	O
No	O
retroperitoneal	O
bleed.	O
2.	O
Increased	O
number	O
and	O
size	O
of	O
pulmonary	O
metastases	O
seen	O
at	O
the	O
visualized	O
portion	O
of	O
the	O
lung	O
bases.	O
MRI	O
from	O
OSH	O
in	O
___:	O
FINDINGS:	O
The	O
sagittal	O
images	O
extended	O
only	O
as	O
far	O
caudally	O
as	O
the	O
T11	O
region.	O
Best	O
seen	O
on	O
the	O
sagittal	O
T1-weighted	O
images	O
are	O
numerous	O
areas	O
of	O
low	O
signal	O
intensity	O
within	O
multiple	O
cervical	O
and	O
thoracic	O
vertebral	O
bodies,	O
consistent	O
with	O
widely	O
disseminated	O
osseous	O
metastatic	O
disease.	O
Within	O
the	O
limitations	O
of	O
this	O
abbreviated	O
study,	O
there	O
is	O
no	O
overt	O
cord	O
compression	O
identified	O
due	O
to	O
metastatic	O
osseous	O
or	O
epidural	O
lesions,	O
although	O
the	O
absence	O
of	O
cross-sectional	O
scans	O
through	O
most	O
of	O
the	O
spine	O
precludes	O
a	O
comprehensive	O
assessment,	O
in	O
this	O
regard.	O
In	O
that	O
light,	O
the	O
available	O
incomplete	O
axial	O
coverage	O
of	O
the	O
cervical	O
spine,	O
as	O
well,	O
is	O
extremely	O
degraded	O
by	O
patient	O
motion.	O
There	O
is	O
demonstration	O
of	O
mild	O
cervical	O
spondylosis	O
at	O
the	O
C4-5	O
through	O
C6-7	O
levels,	O
with	O
tiny	O
osteophytes	O
at	O
C5-6	O
and	O
C6-7	O
contacting	O
the	O
ventral	O
cord	O
margin.	O
There	O
is	O
no	O
definite	O
prevertebral	O
soft	O
tissue	O
swelling.	O
The	O
foramen	O
magnum	O
and	O
its	O
contents	O
are	O
normal.	O
MRI	O
L-spine	O
(___):	O
FINDINGS:	O
Since	O
the	O
prior	O
examination	O
there	O
appears	O
to	O
be	O
some	O
progression	O
of	O
the	O
metastatic	O
lesions	O
involving	O
the	O
left	O
sacral	O
ala	O
and	O
body	O
of	O
the	O
sacrum,	O
extending	O
in	O
the	O
latter	O
area	O
just	O
slightly	O
to	O
the	O
right	O
of	O
midline.	O
The	O
coronal	O
oblique	O
images	O
appear	O
to	O
show	O
infiltration	O
of	O
the	O
left	O
S1	O
through	O
S3	O
foraminal	O
fat.	O
Metastatic	O
disease	O
involving	O
the	O
right	O
iliac	O
bone	O
appears	O
to	O
have	O
progressed,	O
as	O
well.	O
A	O
lesion	O
in	O
the	O
right	O
sacral	O
ala	O
has	O
nearly	O
doubled	O
in	O
size.	O
Also,	O
multiple	O
lumbar	O
spine	O
vertebral	O
signal	O
abnormalities	O
have	O
developed,	O
consistent	O
with	O
dramatic	O
progression	O
of	O
metastatic	O
disease	O
in	O
that	O
locale.	O
However,	O
the	O
central	O
spinal	O
canal	O
does	O
not	O
appear	O
to	O
have	O
any	O
interval	O
new	O
epidural	O
disease	O
develop,	O
and	O
thus	O
there	O
is	O
no	O
apparent	O
compression	O
of	O
the	O
cauda	O
equina.	O
No	O
overt	O
new	O
paraspinal	O
disease	O
is	O
seen.	O
The	O
urinary	O
bladder	O
is	O
moderately	O
dilated.	O
CONCLUSION:	O
Findings	O
appear	O
consistent	O
with	O
dramatic	O
progression	O
of	O
bony	O
metastatic	O
disease,	O
along	O
with	O
infiltration	O
of	O
the	O
left-sided	O
S1-3	O
sacral	O
foramina,	O
as	O
noted	O
above.	O
MRI	O
brain	O
(___):	O
CONCLUSION:	O
No	O
sign	O
of	O
brain	O
metastases.	O
Bony	O
metastases	O
involving	O
the	O
upper	O
cervical	O
spine	O
as	O
noted	O
above.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
metastatic	O
colorectal	O
cancer	O
s/p	O
LAR	O
(___)	O
complicated	O
by	O
lung	O
mets	O
s/p	O
resection	O
with	O
recurrence,	O
and	O
sacral	O
mets	O
currently	O
on	O
cetuximab	O
who	O
presented	O
with	O
acute	O
LLE	O
weakness.	O
#	O
Acute	O
LLE	O
weakness/back	O
pain:	O
The	O
patient	O
has	O
known	O
spinal	O
metastases	O
seen	O
on	O
MRI	O
___.	O
Given	O
her	O
increasing	O
back	O
pain	O
and	O
acute	O
onset	O
of	O
focal	O
weakness,	O
this	O
is	O
concerning	O
for	O
cord	O
compression.	O
She	O
was	O
unable	O
to	O
tolerate	O
the	O
MRI	O
of	O
her	O
lumbar	O
spine	O
while	O
in	O
the	O
ED.	O
She	O
was	O
started	O
on	O
1	O
gm	O
of	O
solumedrol	O
the	O
morning	O
after	O
admission	O
and	O
continued	O
on	O
100	O
mg	O
q6h.	O
This	O
was	O
transitioned	O
to	O
4	O
mg	O
decadron	O
q6h	O
and	O
she	O
was	O
discharged	O
on	O
a	O
slow	O
taper.	O
She	O
underwent	O
an	O
MRI	O
of	O
her	O
lumbar	O
spine	O
which	O
showed	O
no	O
evidence	O
of	O
spinal	O
cord	O
compression,	O
but	O
did	O
show	O
left	O
foraminal	O
nerve	O
compression	O
likely	O
causing	O
her	O
weakness.	O
Radiation	O
oncology	O
was	O
consulted	O
but	O
stated	O
she	O
had	O
already	O
had	O
radiation	O
to	O
that	O
region	O
and	O
could	O
not	O
be	O
given	O
more.	O
The	O
family	O
met	O
with	O
Dr.	O
___	O
the	O
patient	O
and	O
decided	O
to	O
transition	O
to	O
hospice.	O
As	O
she	O
wanted	O
to	O
be	O
discharged	O
over	O
the	O
weekend	O
hospice	O
couldn't	O
be	O
fully	O
set	O
up	O
prior	O
to	O
discharge,	O
but	O
will	O
be	O
set	O
up	O
next	O
week	O
as	O
an	O
outpatient.	O
#	O
Anemia:	O
The	O
patient's	O
Hct	O
ranged	O
from	O
26	O
to	O
34,	O
and	O
prior	O
to	O
discharge	O
was	O
30.8.	O
Her	O
baseline	O
is	O
in	O
the	O
mid-30___.	O
CT	O
abd/pelvis	O
in	O
ED	O
showed	O
no	O
evidence	O
of	O
an	O
RP	O
bleed.	O
Guaiac	O
positive	O
on	O
rectal	B-Lower_gastrointestinal_haemorrhage
exam	O
and	O
may	O
have	O
slow	O
bleeding	B-Lower_gastrointestinal_haemorrhage
from	O
metastatic	O
lesions	O
in	O
the	O
GI	O
tract,	O
however	O
her	O
Hct	O
remained	O
stable.	O
#	O
Mild	O
altered	B-Delirium
mental	B-Delirium
status:	B-Delirium
Neuro	O
consult	O
in	O
the	O
ED	O
was	O
concerned	O
about	O
mild	O
cognitive	B-Unspecified_cognitive_impairment
impairment.	B-Unspecified_cognitive_impairment
She	O
underwent	O
an	O
MRI	O
of	O
the	O
brain	O
which	O
showed	O
no	O
evidence	O
of	O
cerebral	O
metastases.	O
#	O
Hypothroidism:	O
She	O
was	O
continued	O
on	O
levothyroxine.	O
#	O
CODE:	O
DNR/DNI.	O
The	O
patient	O
was	O
full	O
code	O
initially,	O
but	O
after	O
discussion	O
by	O
Dr.	O
___	O
with	O
the	O
patient	O
and	O
her	O
family,	O
she	O
decided	O
to	O
be	O
made	O
DNR/DNI	O
and	O
go	O
home	O
on	O
hospice.	O
Medications	O
on	O
Admission:	O
CYANOCOBALAMIN	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
1,000	O
mcg/mL	O
Solution	O
-	O
qmonth	O
Dilaudid	O
___	O
mg	O
q4	O
PRN	O
PAIN	O
LEVOTHYROXINE	O
[LEVOXYL]	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
100	O
mcg	O
Tablet	O
-	O
1pill	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
LORAZEPAM	O
-	O
1	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
before	O
bedtime	O
as	O
needed	O
for	O
insomnia	O
Medications	O
-	O
OTC	O
CALCIUM	O
CARBONATE-VITAMIN	O
D3	O
[CALTRATE-600	O
PLUS	O
VITAMIN	O
D3]	O
-	O
(OTC)	O
-	O
600	O
mg-400	O
unit	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
DOCUSATE	O
SODIUM	O
[STOOL	O
SOFTENER]	O
-	O
(Prescribed	O
by	O
Other	O
Provider:	O
1	O
every	O
AM&	O
___	O
-	O
Dosage	O
uncertain	O
ERGOCALCIFEROL	O
(VITAMIN	O
D2)	O
[VITAMIN	O
D]	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
1,000	O
unit	O
Capsule	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
MULTIVITAMIN	O
-	O
(OTC)	O
-	O
Capsule	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
once	O
a	O
day	O
SENNA	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
Dosage	O
uncertain	O
Discharge	O
Medications:	O
1.	O
Dexamethasone	O
4	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
six	O
(6)	O
hours:	O
please	O
see	O
attached	O
tapering	O
instructions.	O
Disp:*120	O
Tablet(s)*	O
Refills:*1*	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Capsule(s)*	O
Refills:*2*	O
3.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
Disp:*60	O
Tablet(s)*	O
Refills:*2*	O
4.	O
Levothyroxine	O
100	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
Bisacodyl	O
5	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
___	O
Tablet,	O
Delayed	O
Release	O
(E.C.)s	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
Disp:*50	O
Tablet,	O
Delayed	O
Release	O
(E.C.)(s)*	O
Refills:*2*	O
6.	O
Compazine	O
5	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
nausea.	O
Disp:*60	O
Tablet(s)*	O
Refills:*2*	O
7.	O
Hydromorphone	O
2	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q3H	O
(every	O
3	O
hours)	O
as	O
needed	O
for	O
pain.	O
8.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
once	O
a	O
day.	O
9.	O
Lorazepam	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime	O
as	O
needed	O
for	O
insomnia	O
or	O
anxiety.	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
-	O
Metastatic	O
colon	O
carcinoma	O
Compression	O
of	O
the	O
foraminal	O
nerves	O
of	O
the	O
lumbar	O
spine	O
Secondary	O
-	O
Hypothyroidism	O
Discharge	O
Condition:	O
Stable,	O
with	O
continued	O
left	O
lower	O
extremity	O
weakness.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
due	O
to	O
new	O
lower	O
extremity	O
weakness.	O
You	O
were	O
treated	O
with	O
steroids	O
and	O
underwent	O
an	O
MRI	O
which	O
showed	O
compression	O
of	O
nerves	O
in	O
your	O
back	O
due	O
to	O
metastases	O
causing	O
your	O
weakness.	O
You	O
and	O
your	O
family	O
decided	O
to	O
have	O
you	O
go	O
home	O
with	O
hospice.	O
Medication	O
changes:	O
1.	O
You	O
were	O
started	O
on	O
dexamethasone	O
to	O
decrease	O
swelling	O
in	O
your	O
spine.	O
You	O
will	O
be	O
treated	O
with	O
a	O
taper:	O
-	O
Take	O
4	O
mg	O
of	O
dexamethasone	O
every	O
6	O
hours	O
for	O
2	O
weeks.	O
-	O
Then	O
decrease	O
to	O
4	O
mg	O
every	O
8	O
hours	O
for	O
1	O
week.	O
-	O
Then	O
decrease	O
to	O
4	O
mg	O
twice	O
daily	O
for	O
1	O
week.	O
-	O
Then	O
decrease	O
to	O
4	O
mg	O
daily	O
in	O
the	O
morning.	O
After	O
being	O
on	O
this	O
for	O
a	O
week,	O
please	O
talk	O
to	O
your	O
palliative	O
care	O
doctor	O
or	O
nurse	O
about	O
whether	O
to	O
continue	O
this.	O
2.	O
For	O
pain	O
you	O
can	O
take	O
dilaudid	O
as	O
prescribed.	O
3.	O
To	O
prevent	O
constipation	B-Constipation
you	O
should	O
take	O
100	O
mg	O
of	O
colace	O
twice	O
daily.	O
If	O
you	O
become	O
constipated	B-Constipation
you	O
can	O
take	O
1	O
tablet	O
of	O
senna	O
twice	O
daily,	O
or	O
___	O
tablets	O
of	O
bisacodyl	O
daily.	O
4.	O
If	O
you	O
become	O
nauseated	O
you	O
can	O
take	O
___	O
mg	O
of	O
compazine	O
every	O
6	O
hours.	O
5.	O
For	O
insomnia	O
you	O
can	O
take	O
1	O
mg	O
of	O
ativan	O
as	O
needed.	O
Call	O
your	O
hospice	O
nurse	O
if	O
you	O
develop	O
fevers,	O
chills,	O
shortness	O
of	O
breath,	O
pain,	O
dizziness,	O
or	O
other	O
worrisome	O
symptoms.	O
Followup	O
Instructions:	O
___	O

